ECM
NVIV

Element Capital Management’s InVivo Therapeutics Holdings Corp NVIV Stock Holding History

Element Capital Management’s Portfolio NVIV Stock Details NVIV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-7
Closed -$368K – 133
2017
Q2 		$368K Buy
+7
New +$382K 0.07% 54

Other funds holding NVIV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ICM
IMS Capital Management Portland, Oregon $217M AUM 18.69% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
WF
Welch & Forbes Boston, Massachusetts $7.73B AUM 14.94% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
RJA
Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return

Element Capital Management's NVIV Position: Q3 2017 in Review

Element Capital Management sold out of InVivo Therapeutics Holdings Corp (NVIV) in Q3 2017, closing a stake of 7 shares — an estimated $368K sold.

Element Capital Management first reported a position in NVIV in Q2 2017 and held it in 1 quarter. The position peaked at $368K in Q2 2017. 33 funds tracked by Wall St. Rank hold NVIV as of Q3 2017.

  • Element Capital Management reported no remaining InVivo Therapeutics Holdings Corp position as of Q3 2017 after selling out during the quarter.
  • Element Capital Management sold 7 InVivo Therapeutics Holdings Corp shares in Q3 2017, an estimated $368K.
  • Element Capital Management first reported a position in InVivo Therapeutics Holdings Corp in Q2 2017 and held it in 1 quarter.
  • Element Capital Management's InVivo Therapeutics Holdings Corp position peaked at $368K in Q2 2017.
  • 33 funds tracked by Wall St. Rank held InVivo Therapeutics Holdings Corp as of Q3 2017.

Based on Element Capital Management's 13F filing for Q3 2017, filed 13 Nov 2017.